Serum Institute of India writes to PMO proposing reforms in drug regulatory system - Android

New Delhi, Mar 04: The world's largest vaccine manufacturer by volume, Serum Institute of India, has written to the Prime Minister's Office proposing reforms in the existing drug regulatory system, including allowing manufacturing and stockpiling of non-COVID vaccines while undergoing